Gateway Biotechnology Inc.
Gateway Biotechnology focuses on developing drugs to combat hearing disorders such as hearing loss and tinnitus. With a decade of research funded by seven SBIR/STTR awards from the National Institutes of Health (NIH), we have advanced all three of our pipelines to the completion of preclinical studies, and our lead drug candidate is undergoing a Phase II Clinical Trial sponsored by a DoD contract. Our innovative approach that targets multiple pathways is expected to bring the first-ever FDA-appr
Connect with Gateway Biotechnology Inc.